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Soft Tissue Leiomyosarcoma is a relatively rare 
malignant tumor. It may be difficult to be distinguished 
from gastrointestinal stromal tumors and Schwann cell 
neoplasms. To make a correct identification of soft 
tissue leiomyosarcoma, immunostaining with several 
smooth muscle differentiation markers (actin, calponin 
and desmin), and negative staining results with S100 
(to rule out Schwann cell neoplasm), c-kit and CD34 
(to rule out gastrointestinal stromal tumors) is needed. 
Clinics and pathology 
Clinics 
The annual new cases in the U.S. are over 6,000. The 
five year survival rate after diagnosis is about 50%. 
Genes 
Soft tissue leiomyosarcoma was classified based on 
salient gene expression characteristics. Three types of 
leiomyosarcoma were proposed: 1) "Simplification" of 
gene expression in leiomyosarcoma, characterized by 
dramatic down regulation of large number of genes; 2) 
"Inflammation related" gene expression, characterized 
by the prominent presence of lymphocyte specific 
genes in the analysis; and 3) "neural" gene expression, 
characterized by neuronal gene expression. Among 
these subtypes, simplification gene expression is 
associated with the poorest prognosis, while 
inflammation related one the best. 
Prognosis 
Local recurrent tumor, positive surgical margins, >50 
years age, >20 mitoses per high power field are 
adversely associated with survival. 
 
 










Phylogenetic tree of leimyosarcomas and normal smooth muscle. Expression levels of 92 cDNA sequences from table III through V were 
analyzed for 11 leiomyosarcoma tissues. Experiment cluster analysis was performed using Michael Eisen's cluster tool and tree view. 
Data input and normalization of individual experiments were performed in GeneSpringTM 4.2 before imported into cluster tool. Red 
indicates high expression level, while green for low, black for no expression. The cutoff expression level for non-expressor was set at 200 
arbitary units. Pathological grade (G) for each tumor is indicated, so is metastasis (r) if it is present. 
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